Aspire Allergy & Sinus - Buyer Spotlight
Aspire Allergy & Sinus was formed out of private equity firm Source Capital's 2018 partnership with Austin based Texan Allergy & Sinus Center. Source Capital makes traditional private equity and direct lending investments, and has similar healthcare investments in CRH Healthcare (anesthesia practice management) and Southern Dental Alliance.
Since its founding in 2018, Aspire Allergy & Sinus has partnered with two additional groups in Colorado and Florida. Like Texan Allergy & Sinus Center, these two additional acquisition were small relative to most of the other early private equity deals (e.g. 200+ physician ENT & Allergy Associates).
For more information about Physicians First and our investment banking solution for doctors, download our current ENT & Allergy Report here.
This post is for informational purposes only and does not constitute an offer, invitation, solicitation, or recommendation to buy, sell, subscribe for, or issue any securities. While the information provided herein is believed to be accurate and reliable, 127 Capital, LLC (“Physicians First”) and Ashland Securities, LLC make no representations or warranties, expressed or implied, as to the accuracy or completeness of such information. All information contained herein is preliminary, limited and subject to completion, correction or amendment. It should not be construed as investment, legal, or tax advice and may not be reproduced or distributed to any person. Certain Principals of Physicians First are registered representatives of Ashland Securities, LLC Member FINRA, SIPC. Physicians First and Ashland Securities, LLC are separate and unaffiliated entities. Securities and Investment Banking Services are offered through Ashland Securities, LLC.